CytomX Therapeutics, Inc. (CTMX) Form 10-K Annual Reports
CytomX Therapeutics, Inc. (CTMX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CTMX
CIK: 1501989
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerMarcus Lindner
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4/A | 2026-10-16 | 2025-11-06 | FORM 4/A | 0001610717-26-000442 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005484 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001907884-26-000014 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000448 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001193125-26-338121 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338009 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-337950 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001610717-26-000351 | View SEC Doc Filr Page |
| 3 | 2026-08-05 | 2026-08-03 | FORM 3 | 0001610717-26-000350 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0000070858-26-000395 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-24 | FORM 4 | 0001610717-26-000345 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-24 | FORM 3 | 0001610717-26-000344 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002247 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-24 | 8-K | 0001193125-26-316929 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000280 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-17 | 8-K | 0001193125-26-277631 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000279 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000278 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000277 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000276 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000275 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001610717-26-000274 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001610717-26-000229 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-05-29 | 8-K | 0001193125-26-255467 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001013594-26-000617 | View SEC Doc Filr Page |